---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-001552"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2022-01-19T23:59:59+00:00"
generated_at: "2026-06-27T17:24:26.470417+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# LifeMD reports FY2021 preliminary revenue of $92.9M, +149% YoY; FY2022 guidance $142-148M

## Summary
- Preliminary Q4 2021 revenue $27.4M; FY2021 revenue $92.9M (149% YoY growth).
- FY2022 revenue guidance $142-148M; Adj. EBITDA loss guidance ($14M)-($20M).
- Q1 2022 revenue guidance $30-32M; Adj. EBITDA loss ($6.5M)-($7.5M).
- Reaffirms Adj. EBITDA profitability target by Q4 2022.
- Company highlights acquisition of Cleared and launch of LifeMD Virtual Primary Care Platform.

## SEC filing metadata
- accession: 0001493152-22-001552
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2022-01-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000149315222001552/0001493152-22-001552-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000149315222001552/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-001552
- JSON: https://secwatch.observer/filing/0001493152-22-001552.json
- Plain text: https://secwatch.observer/filing/0001493152-22-001552.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.